AFP and prostate carcinoma: For example, the molecular detection of alpha fetoprotein (AFP) enables early detection of liver cancer and improvement of prognosis [4], while the introduction of prostate specific antigen (PSA) screening significantly reduces the mortality of prostate cancer [5].